SES AI Corp 8-K

What Happened
SES AI Corporation (SES) announced in an 8‑K filed July 20, 2026 that on July 17, 2026 it received a notice from the New York Stock Exchange (NYSE) notifying the company it is not in compliance with Section 802.01C because the average closing price of its Class A common stock was under $1.00 over a consecutive 30 trading‑day period. The notice does not cause immediate delisting; SES says it will notify the NYSE of its intent to regain compliance and will consider alternatives, including actions that may require shareholder approval.

Key Details

• Notice date: July 17, 2026; 8‑K filed and press release issued July 20, 2026 (Exhibit 99.1).
• NYSE threshold: average closing price below $1.00 over a consecutive 30 trading‑day period (non‑compliance cited).
• Cure period: SES has six months from receipt of the notice to regain compliance. Compliance can be achieved if on the last trading day of any calendar month during the cure period the closing price is ≥ $1.00 and the 30‑trading‑day average is ≥ $1.00.
• If SES pursues a cure that requires shareholder approval (e.g., a reverse stock split), the NYSE may deem the price condition cured if the post‑action price exceeds $1.00 and remains above $1.00 for the following 30 trading days.
• SES’s Class A shares will continue to trade on the NYSE during the cure period, subject to other listing standards.

Why It Matters
A continued failure to meet the NYSE minimum price standard could eventually lead to delisting, which would reduce liquidity and could limit certain investors’ ability to hold the stock. The company now has a defined six‑month window to restore compliance or pursue remedial actions (such as a reverse split) that may require shareholder approval. Investors should monitor SES announcements for any proposed actions, changes in trading price, and updates on compliance progress.